Category: Neuromuscular Blockade
Rachel C. Wolfe, Pharm.D., M.H.A., BCCCP
Pharmacists are well positioned to advocate for safe management of patients undergoing neuromuscular blockade and reversal and should expand their knowledge on this topic.
Deborah Wagner, Pharm.D., FASHP
Pharmacy and therapeutics (P&T) committees have the leadership necessary to create balance from the need and want perspective to what is fiscally reasonable. The case of neuromuscular blocker reversal agents fits these criteria uniquely.